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ABSTRACT In their active state, b2-integrins, such as LFA-1, mediate the ﬁrm arrest of leukocytes by binding intercellular
adhesion molecules (ICAMs) expressed on endothelium. Although the primary function of LFA-1 is assumed to be the ability to
mediate ﬁrm adhesion, recent work has shown that LFA-1 can contribute to cell tethering and rolling under hydrodynamic ﬂow,
a role previously largely attributed to the selectins. The inserted (I) domain of LFA-1 has recently been crystallized in the wild-
type (wt) and locked-open conformations and has been shown to, respectively, support rolling and ﬁrm adhesion under ﬂow
when expressed in aLb2 heterodimers or as isolated domains on cells. Here, we report results from cell-free adhesion assays
where wt I-domain-coated polystyrene particles were allowed to interact with ICAM-1-coated surfaces in shear ﬂow. We show
that wt I-domain can independently mediate the capture of particles from ﬂow and support their rolling on ICAM-1 surfaces in
a manner similar to how carbohydrate-selectin interactions mediate rolling. Adhesion is speciﬁc and blocked by appropriate
antibodies. We also show that the rolling velocity of I-domain-coated particles depends on the wall shear stress in ﬂow chamber,
I-domain site density on microsphere surfaces, and ICAM-1 site density on substrate surfaces. Furthermore, we show that
rolling is less sensitive to wall shear stress and ICAM-1 substrate density at high density of I-domain on the microsphere
surface. Computer simulations using adhesive dynamics can recreate bead rolling dynamics and show that the
mechanochemical properties of ICAM-1-I-domain interactions are similar to those of carbohydrate-selectin interactions.
Understanding the biophysics of adhesion mediated by the I-domain of LFA-1 can elucidate the complex roles this integrin plays
in leukocyte adhesion in inﬂammation.
INTRODUCTION
Inﬂammation, a natural process by which living tissues
respond to injury, is often accompanied by changes in blood
ﬂow, increased permeability of blood vessels, and adhesion
and migration of leukocytes from blood into tissues. Leu-
kocyte adhesion to the endothelium and transendothelial
migration in response to inﬂammatory stimuli occur via mul-
tiple receptor-ligand interactions (1). The endothelial selectins
(P- and E-selectin) can mediate the initial, transient (rolling)
adhesion of leukocytes onto the endothelium via interaction
with their counterreceptors expressed on leukocyte cell sur-
faces (1,2). This rolling adhesion is a prerequisite for the ﬁrm
arrest of leukocytes to the endothelium that is mediated by
activated leukocyte b2-integrins binding to endothelial-
expressed intercellular adhesion molecules (ICAMs) (2–5).
b2-integrins are also believed to be involved in the trans-
endothelial migration of leukocytes that follows their ﬁrm
arrest onto the endothelium, though platelet endothelial cell
adhesion molecule-1 (PECAM-1) is also thought to play a
major role in extravasation (6,7). Lymphocyte function-
associated antigen-1 (LFA-1) is the primary b2-integrin in-
volved in the ﬁrm arrest of leukocytes to the vascular wall
during the inﬂammatory response (8), and ICAM-1 is the
major endothelial adhesion ligand to LFA-1. LFA-1, also
known as aLb2, is constitutively expressed on leukocyte
surface in a low afﬁnity state but can switch to a high afﬁnity
state upon receiving signals transmitted from within leu-
kocytes after receptor binding or activation (1,9). The precise
contribution of LFA-1 before activation is unclear. The
lymphocyte integrin a4b1 can exist in two states and in the
low afﬁnity state can support rolling and in the high afﬁnity
state can support ﬁrm adhesion (10). Whether LFA-1 can
support or supplement adhesion in the low afﬁnity state has
perhaps been occluded by its coexpression with leukocyte
selectins. Recent work shows that LFA-1, along with other
b2-integrins such as Mac-1, has a role in stabilizing selectin-
mediated rolling interaction, resulting in slow leukocyte
rolling on inﬂamed endothelium in vivo (11–15).
To understand LFA-1 afﬁnity regulation and its effect on
leukocyte adhesion, researchers have focused attention on
the adhesion domains in LFA-1. Three domains, inserted (I),
b-propeller, and I-like domain, located in the headpiece of
LFA-1 have been suggested to be involved in ligand bind-
ing or in the regulation of ligand binding (16); however, the
I-domain serves as the primary ICAM-1 binding site on
LFA-1. This domain has recently been crystallized in the in-
termediate and open conformation (closed conformation was
crystallized earlier by Qu and Leahy (17)); and afﬁnity mea-
surements show that the closed conformation has low afﬁnity
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to ICAM-1, similar to wild-type (wt) I-domain, whereas the
open conformation has a high afﬁnity to ICAM-1 (18).
The notion that I-domain can support rolling is supported
by experiments in which the low afﬁnity (wt) state, expressed
on cells in isolation from other domains, can support roll-
ing adhesion on ICAM-1 surfaces under shear ﬂow in vitro
(10,19). Other work has shown that LFA-1 as an intact mol-
ecule on cell surfaces can also support rolling adhesion on
ICAM-1 in shear ﬂow separate from, but similar to, selectin-
mediated rolling adhesion (20). Although these studies show
the ability of low afﬁnity LFA-1 and its I-domain to form
and maintain transient adhesion, they do not fully explore
their ability to mediate cell tethering from ﬂow since the ini-
tial contact between LFA-1/I-domain-expressing cells and
ICAM-1 substrates occurred at very low shear rate or in the
absence of ﬂow (i.e., cells were allowed to settle on substrate
before initiating ﬂow (20)). In addition, they do not allow the
ability to vary systematically the density of I-domain mol-
ecules and study the effects on rolling dynamics and teth-
ering.
Here, we illustrate the ability of wt I-domain to mediate
tethering andmaintain stable rolling in a cell-free in vitro ﬂow
system up to physiological shear rates. We also explore the
effect of molecule (I-domain and ICAM-1) density on rolling
dynamics. To do this, puriﬁed I-domain was attached to the
surface of polystyrene microspheres via avidin-biotin link-
age; and after I-domain attachment, particles were allowed
to interact with ICAM-1 surfaces under ﬂow. We show that
I-domain can independently mediate the capture of particles
from ﬂow and support their rolling on ICAM-1 surfaces, in
a fashion similar to that displayed by carbohydrate-selectin
interactions in a cell-free system (21). Rolling is speciﬁc and
blocked by appropriate antibodies. We also show that the
rolling velocity of I-domain particles depends on the wall
shear stress in the ﬂow chamber, I-domain site density on
microspheres and ICAM-1 site density on the substrate sur-
face. Furthermore, we show that rolling is less sensitive to
wall shear stress and ICAM-1 substrate density at a high
density of I-domain on microsphere surfaces. An analysis of
rolling dynamics using adhesive dynamics (AD) suggests that
the off rate and reactive compliance for I-domain-ICAM-1
interactions are 4 s1 and 0.1 A˚, respectively, rather close to
the values of these parameters for selectin-carbohydrate in-
teractions and well within the rolling envelop in the state
diagram relating mechanicochemical properties of adhesion
molecules to rolling (22). Therefore, our ﬁndings support the
notion that I-domain (and LFA-1) can act as a rolling ligand in
tandem with selectin interactions before leukocyte and
integrin activation. The overall purpose of this work is to
further understand the contribution of LFA-1 to the transition
from rolling to ﬁrm arrest that must occur for neutrophils and
other leukocytes to marginate into tissues during inﬂamma-
tion response by elucidating the biophysics of the adhesion
mediated by the inserted- (I)-domain that is known to be
a major adhesion domain on LFA-1.
MATERIALS AND METHODS
Adhesion molecules and antibodies
Recombinant human ICAM-1/Fc chimera (mouse IgG1) and anti-ICAM-1
monoclonal antibody (mAb) BBIG-I1 were purchased from R & D Systems
(Minneapolis, MN). Fluorosceine Iso-thio-cyanate (FITC)-labeled anti-
mouse IgG1 was purchased from Pharmingen (San Diego, CA). Sialyl
LewisX carbohydrate (sLeX) was purchased from Glycotech (Rockville,
MD). Anti-human aL I-domain monoclonal antibodies, TS1/11, TS1/12, and
TS2/6 were previously described (23,24).
Construction and expression of biotinylated
wt LFA-1 I-domain
A BirA enzyme recognition tag (LGGIFEAMKMELRD) was fused to the
N-terminal of wt aL I-domain (Gly
128–Y307) through Gly-Gly-Gly-Ser linker
(18,25–27). The cDNA was cloned into the NdeI and BamHI sites of the
pET-20b vector. Protein was expressed in Escherichia coli BL21 DE3
(Novagen, La Jolla, CA). The transformed bacteria were cultured in rich
media (20 g/L tryptone, 10 g/L yeast extract, 5 g/L NaCl, 20 ml/L glycerol,
50 mMK2HPO4, 10 mMMgCl2, 10 g/L glucose, 100 mg/L ampicillin). The
expression was induced by addition of isopropyl a-D-thiogalactopyranoside
(IPTG) (Invitrogen, Carlsbad, CA) to a ﬁnal concentration of 1 mM at
OD600 nm of 0.6–1.0. After 3 h of induction at 37C, bacteria were
harvested by centrifugation and frozen at 20C. Frozen cells were
resuspended in Tris buffered saline (TBS) with 1 mg/mL lysozyme and then
disrupted by ultrasonication. Inclusion bodies were harvested by centrifu-
gation. After extensive washing with washing buffer (20 mM Tris (pH 8.0),
23% (w/v) sucrose, 0.5% (v/v) Triton X-100, 1 mM EDTA), the pellet was
solubilized by adding 6 M Guanidine HCl, 50 mM Tris (pH 8.0), 1 mM
Dithiothreitol (DTT). I-domain was refolded in TBS-glycerol buffer (20 mM
Tris (pH 8.0), 100 mM NaCl, 5% glycerol) and then puriﬁed by Superdex
S-200 (Amersham Biosciences, Piscataway, NJ) gel-ﬁltration in phosphate-
buffered saline (PBS) after ammonium sulfate precipitation. Site-directed
biotinylation was performed using the BirA enzyme (Avidity, Denver, CO).
Typically, I-domain at concentrations of 1–2 mg/ml was incubated with
BirA (15–20 mg/ml) at room temperature overnight in a buffer containing 20
mM Tris (pH 8.0), 100 mM NaCl, 10 mMMgOAc, 50 mM Bicine (pH 8.3),
10 mM ATP, and 50 mM biotin. The unbound biotin was completely
removed by passing the sample through a Superdex S-200 column
(Amersham) in a running buffer (20 mM Tris (pH 8.0), 150 mM NaCl).
Substrate preparation
ICAM-1 surfaces were prepared as previously described (28). Brieﬂy,
double-well, rectangular ﬂexiperm gaskets were placed on microscope slides
cut from bacteriological polystyrene dishes. The surface enclosed by one of
the two wells was incubated overnight with 374 mL ICAM-1 in binding
buffer (0.1 M NaHCO3) at 1.25, 2.5, or 5 mg/mL (sample) and the other with
binding buffer only (control). After incubation, slides were washed and
blocked for 1 h with 2% solution of denatured bovine serum albumin (BSA)
in Dulbecco’s phosphate-buffered saline (DPBS). Before use in laminar
ﬂow, slides were incubated with 1%Tween 20 in DPBS for;2 min. ICAM-1
density determination was as previously described (28). Brieﬂy, eight-well,
rectangular, ﬂexiperm gaskets on polystyrene slides were incubated with
ICAM-1 at desired concentrations and blocked with BSA similar to ﬂow
experiment. ICAM-1-coated wells were then incubated with a saturating
concentration of FITC-labeled aICAM-1 mAb (BBIG-I1). Fluorescence
intensity was obtained using FeliX software (Photon Technologies, Severna
Park, MD) and a Nikon Diaphot inverted microscope (Melville, NY)
equipped with a FITC cube. ICAM-1 site density (molecules/mm2) was
obtained using calibration curves generated by measuring the ﬂuorescence
of known concentration of FITC-aICAM-1.
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Microsphere preparation
Biotinylated I-domain and sLeX were diluted to 5 mg/mL in DPBS1 (DPBS,
1% BSA, 1 mM Ca21, 2 mM Mg21, pH ¼ 7.4). These two solutions were
then mixed at ratios between 0% and 100% I-domain. A total of 106
SuperAvidin-coated beads (;10 mm, 1.060 g/cm3, Bangs Laboratories,
Fishers, IN) were coated with 100 mL of solutions containing both I-domain
and sLeX at different ratios for 1 h at room temperature. Since a microsphere-
coating concentration of 5 mg/mL is saturating, adding a non-ICAM-1
functional molecule, like sLeX, in the coating solution to compete for biotin
binding sites on microspheres can guarantee a signiﬁcant reduction in
I-domain site density with a decrease in the amount of I-domain in coat-
ing solution. Control beads were prepared by coating microspheres with 100
mL sLeX solution at 5 mg/mL. After incubation, beads were washed twice
in DPBS1 and resuspended in 2 mL DPBS1 until ready for use.
Microsphere I-domain site density determination
Three different anti-human aL I-domain mAbs, TS1/11, TS1/12, and TS2/6,
were used to determine surface density of wt I-domain on microsphere
surface (10). Brieﬂy, 105 I-domain-coated microspheres were incubated with
100 mL of primary antibody (20 mg/mL in DPBS1) for 1 h. After primary
antibody incubation, beads were washed twice in DPBS1 and incubated
with 100 mL of FITC-labeled anti-mouse IgG1 mAb (30 mg/mL). Fluo-
rescence intensity was measured using ﬂow cytometry, and I-domain site
density was estimated as previously described (29). Brieﬂy, ﬂuorescence
shifts of I-domain particles were converted to molecules of equivalent sol-
uble ﬂuorochrome (MESF) using a calibration curve relating mean peak
ﬂuorescence of Quantum 26 calibration beads (Bangs Laboratories) to their
MESF. The number of surface-bound I-domain was determined by con-
verting the corresponding MESF value of I-domain particles to site density
using the ﬂuorochrome/protein ratio of FITC-conjugated secondary
antibody and assuming a 1:1 binding between the I-domain and the primary
and the secondary antibody.
Laminar ﬂow assay
A straight-channel, parallel-plate ﬂow chamber was used for laminar ﬂow
assays. Brieﬂy, a straight channel template was placed over an ICAM-1-
coated slide. The template and slide were then placed in the bottom well of
the ﬂow chamber. The ﬂow chamber experiment was as previously de-
scribed (21,29), where the assembled chamber was mounted on the stage of
a Nikon Diaphot inverted microscope with phase-contrast optics (Nikon,
Tokyo, Japan). A bead concentration of 106 I-domain-coated or sLeX-coated
microspheres in 2 mL DBPS1 was used, and ﬂow was initiated with an
infusion/withdrawal syringe pump (Harvard Apparatus, South Natick, MA).
Experiments were recorded using a Cohu black and white charge-coupled
device camera (Cohu, San Diego, CA) and a Sony SVO-9500MD S-VHS
recorder (Sony Medical Systems, Montvale, NJ). Wall shear stress in ﬂow
chamber (tw) was calculated as previously described (29). To conﬁrm the
dependence of I-domain-ICAM-1 interaction on divalent cations, Ca21 and
Mg21, 10 mM EDTA was added to perfusion buffer (DPBS1) to remove
these ions.
Data analysis
Rolling velocities were obtained through digital image analysis of video
records of adhesion experiments using LabView software (National Instru-
ment, Austin, TX), and the average rolling velocities were obtained by
taking the mean velocity of at least 10 particles continuously rolling for 3 s
or longer (21). Rolling is deﬁned as particles moving ,10% of free stream
velocity. Rolling ﬂux of interacting beads was obtained manually by
counting the number of rolling beads in the window of view (0.32 mm2) over
a period of 1 min. Instantaneous rolling velocities (Vinst) were determined by
dividing the displacement of particle by the time between captured frames.
Vinst data were obtained every one-sixth of a second. The standard deviation
of the instantaneous rolling velocity, root mean-square rolling velocity
(Vrms), of each particle was calculated as previously described (30). Unless
otherwise stated, error bars were plotted using standard error calculation.
Data plots show the average of at least three experiments. Differences in the
level of adhesion for the different conditions tested were examined using
two-tailed Student’s t-test. A value of p , 0.05 was considered statically
signiﬁcant.
Adhesive dynamics
The AD method that has been previously described was used to analyze the
rolling dynamics of I-domain-ICAM-1 interactions (22,31,32). Brieﬂy, AD
simulates the adhesive behavior of a rigid sphere (i.e., bead or model cell) in
near contact with a wall (i.e., slide or endothelium) under shear ﬂow. At each
time step, a contact zone is deﬁned between the bead and the uniformly
reactive planar surface, and randomly distributed cell-surface receptors
within that zone are tested for bond formation according to probabilities
calculated from bond-length-dependent kinetic rates. All preexisting bonds
are then tested for breakage, also according to bond-length-dependent rates.
If a bond forms, over its lifetime it is represented by a linear spring whose
endpoints remain ﬁxed with respect to either surface. The orientation and
length of each spring speciﬁes the instantaneous force and torque exerted by
that bond on the sphere and also its probability for breakage per unit time.
A summation of external forces and torques due to bonds, gravity, and
nonspeciﬁc steric repulsion enables a mobility calculation to determine the
translational and rotational velocities of the sphere under ﬂow. For a single
particle in low Reynolds number Couette ﬂow, the mobility function is
available as a closed-form solution for all modes of motion (31,33,34).
Finally, cell and bond positions are updated according to the kinematics of
cell motion, neglecting inertia and assuming velocities to be constant over
each time step of 0.1 ms. This process is repeated until 10 s of simulation
time have elapsed. Each reported average rolling velocity represents the
averaged results of n $ 7 realizations.
Calculation of the probability of breakage, Pr ¼ 1  exp(krDt), employs
the Bell model describing the kinetics of single biomolecular bond failure
(35),
kr ¼ k0r exp
g sjxb  lj
kBT
 
; (1)
which relates the rate of dissociation kr to the magnitude of the force on the
bond, calculated using the Hookean spring constant s, and deviation bond
length jxb  lj, where xb is the bond length and l is the unstressed,
equilibrium bond length. The unstressed off rate k0r and reactive compliance
g have been determined experimentally for LFA-1-ICAM-1 bonds using
atomic force microscopy measurements (36). BIAcore measurements have
yielded values of k0r for the aL integrin I-domain-ICAM-1 interactions (18).
Once the rate of dissociation is set by Eq. 1, the rate of formation directly
follows from the Boltzmann distribution for afﬁnity (37),
kf ¼ k0f exp s
y l g  12jxb  lj
 

KBT
 
; (2)
permitting the calculation of the probability of bond formation Pf ¼ 1 
exp(kfDt). The two-dimensional intrinsic on rate k
0
f of the I-domain-ICAM-1
bond, whose molecular participants are ﬁxed on respective surfaces, has
not been measured experimentally and remains a tunable parameter. The
expression for the overall forward binding rate is also a function of the wall
surface ligand density and the relative velocity between the two surfaces,
exhibiting a ﬁrst-order dependence on the Peclet number (38). Physical
parameters used in the simulation are listed in Table 1.
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RESULTS
I-domain density on microspheres
Microsphere I-domain site densities were determined by ﬂow
cytometry. Fig. 1 shows the ﬂuorescence histograms obtained
for I-domain-coated microspheres stained with primary anti-
body TS2/6 (;20 mg/mL). The control histogram represents
microspheres coated with sLeX only. Rightward shift in ﬂuo-
rescence intensity of I-domain-coated beads from control
conﬁrms the presence of I-domain on the microsphere sur-
face. As shown in Fig. 1, the shift in ﬂuorescence intensity
from control beads increased with increasing I-domain con-
centration in solution. Fluorescence intensity data were re-
lated to molecular density using ﬂuorescent calibration
beads. Table 2 lists the average I-domain density on the mi-
crosphere surface obtained from ﬂow cytometry measure-
ments with all three antibodies, TS1/11, TS1/12, and TS2/6,
anti-human aL I-domain mAbs. Microspheres coated with
2.5 mg/ml I-domain in solution resulted in an I-domain site
density of 252 6 15 sites/mm2 on the microsphere surface.
This site density is similar to the amount of b2-integrin,
;300 sites/mm2, on resting neutrophils (based on an ap-
parent surface area of 227 mm2) (39,40).
Wt I-domain speciﬁcally mediates the dynamic
adhesion of microspheres on ICAM-1 substrate
I-domain-coated particles were allowed to interact with the
ICAM-1-coated surface in continuous laminar shear ﬂow in
a parallel plate ﬂow chamber. Wt I-domain mediated the
capture of polystyrene microspheres from free stream and
maintained slow rolling of these microspheres on ICAM-1.
Fig. 2 shows rolling and ﬁrm binding ﬂux of microspheres
on surfaces with ;210 sites/mm2 ICAM-1 at a wall shear
stress of ;1.3 dynes/cm2. Firm adhesion of microspheres
was not observed with any of the I-domain site densities or
ICAM-1 surface densities studied. In addition, microspheres
coated with only sLeX (5 mg/mL) did not roll on or ﬁrmly
adhere to ICAM-1 surfaces, and microspheres coated with
anti-ICAM-1 mAb (BBIG-I1) showed no rolling and only
ﬁrm adhesion on ICAM-1 (data not shown). The presence of
EDTA in the perfusion buffer abolished rolling interaction
between I-domain particles and ICAM-1 surfaces (Fig. 2).
Control experiments with the anti-human aL mAb TS 2/6
TABLE 1 Values of physical parameters used in simulations
Parameter Deﬁnition Value Reference
a Particle radius 5 mm (46)
m Viscosity 0.01 P
r Fluid density 1 g/cm3
Dr Density difference 0.05 g/cm3
l Equilibrium bond length 70 nm (47)
s Spring constant 100 dyn/cm (48)
T Temperature 298 K
k0f Intrinsic on rate 0.3 mm
2/s
g Reactive compliance 0.1 A˚
k0r Unstressed off rate 4.0 s
1
FIGURE 1 Fluorescence histogram for SuperAvidin microspheres (9.95
mm) incubated with 5 mg/mL solutions containing 0% (control), 30%,
50%, 70%, and 100% I-domain. Primary antibody: TS2/6 (1:10 dilution).
Secondary antibody: FITC-labeled anti-mouse IgG (25 mg/mL).
FIGURE 2 Rolling and binding ﬂux of beads coated with 1730 (100%)
and 824 (70%) sites of I-domain, 2800 sites/mm2 of anti-ICAM-1 (100%),
and 1321 sites/mm2 of sLeX (100%) on 210 sites/mm2 ICAM-1 surfaces (n$
4) at 130 s1. Beads were suspended in PBS1 (1% BSA, 1 mM Ca21, 2 mM
Mg21). The experiment with EDTA was with PBS1 w/o ions. Field of
view ¼ 0.32 mm2, time ¼ 1 min, and TS2/6 concentration ¼ ;20 mg/mL.
*Baseline ﬂux ¼ 264 beads/mm23min.
TABLE 2 Average I-domain site density (sites/mm2) on
microsphere surface for TS2/6, TS1/11, and TS1/12 staining
Coating concentration
(mg/ml I-domain)
Average I-domain
site density (sites/mm2) Standard error
0 0 0
1.5 94 12
2.5 252 15
3.5 824 49
5.0 1731 165
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signiﬁcantly reduced the level of rolling adhesion with
I-domain beads on ICAM-1.
Rolling adhesion of microspheres is a function of
I-domain site density, ICAM-1 substrate density,
and wall shear stress in ﬂow chamber
Average rolling velocities for I-domain-coated microspheres
on ICAM-1 were measured at different microsphere and
substrate molecule densities and wall shear stresses. Fig. 3
shows the microsphere rolling velocity as a function of wall
shear stress at different I-domain microsphere and ICAM-1
surface densities. At a given ICAM-1 substrate density,
microsphere rolling velocity decreases with increasing
microsphere I-domain site density for all shear stress studied.
The sensitivity of rolling velocity to I-domain density ap-
pears to increase with increasing wall shear stress within the
ﬂow chamber (see Fig. 3 A, inset) and decreasing ICAM-1
substrate density. Similarly, at a given I-domain site den-
sity, rolling velocity decreases with increasing ICAM-1 site
density at all shear stresses (e.g., compare squares in Fig.
3, A–C; P , 0.05). As also shown in Fig. 3, the rolling
velocity of I-domain microspheres increased signiﬁcantly
with an increase in the wall shear within the ﬂow chamber at
most I-domain and ICAM-1 densities studied, and the mag-
nitude of increase depended on the I-domain and ICAM-1
density.
To further elucidate the apparent coupling effect of shear
stress and density of adhesion molecules on rolling velocity,
we present rolling velocity data in contour plots. Fig. 4
shows the contour plots of I-domain microsphere rolling
velocity at different shear stresses within the ﬂow chamber
for different microsphere and substrate molecular densities.
In Fig. 4 A, rolling velocity progressively becomes insensi-
tive to wall shear stress as the I-domain site density on mi-
crospheres increased. Similarly, Fig. 4 B shows a region, at
low wall shear stress and high ICAM-1 density, where rolling
velocity is insensitive to shear stress.
Instantaneous rolling velocity and its ﬂuctuation
with time
Instantaneous rolling velocities of I-domain-coated micro-
spheres on ICAM-1 surfaces were calculated as described in
Materials and Methods. Fig. 5 shows representative instan-
taneous rolling velocity traces for I-domain microspheres at
different I-domain and ICAM-1 site densities and at different
wall shear stresses. The velocities with which wt I-domain
particles interacted with ICAM-1 surfaces vary with time at
all conditions studied. These particles also displayed brief
pauses (periods of zero velocity) when interacting with
ICAM-1 substrates. Furthermore, the amount of time paused
and the duration of pausing decreased with a decrease in
I-domain or ICAM-1 densities on microspheres or substrate
FIGURE 3 Rolling velocity as a function of wall shear rate for I-domain
microspheres on surfaces coated with (A) 1.25, (B) 2.5, and (C) 5.0 mg/mL
of ICAM-1. Beads were suspended in PBS1 (1% BSA, 1 mM Ca21, 2 mM
Mg21). Error bars ¼ standard error (n $ 4); #no signiﬁcant increase from
previous shear rate (P . 0.05). (Inset) (A) Rolling velocity of I-domain
microspheres at 70 s1 and 180 s1 shear rates (*P , 0.0001, #P . 0.05).
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surfaces, respectively, but increased with a decrease in wall
shear stress within the ﬂow chamber. Similarly, the variation
of rolling velocity with time decreases with decreasing wall
shear stress and increasing I-domain and ICAM-1 densities.
To quantify the ﬂuctuations in rolling velocity, the root
mean-squares (RMS) of the I-domain microsphere rolling
velocity were calculated for the different molecular site
densities and wall shear stresses studied. Fig. 6 shows plots
of calculated average RMS rolling velocities for I-domain
microspheres as a function of wall shear stress at different
I-domain surface densities (A) and as a function of ICAM-1
substrate site density (B). As expected, average RMS rolling
velocity signiﬁcantly decreases with increase in microsphere
I-domain site density at a single wall shear stress. Similarly,
average RMS rolling velocity decreases with increasing
ICAM-1 site density on the substrate surface. However, the
effect of wall shear stress on the ﬂuctuation in I-domain
microsphere rolling velocity is not clear since there appears
to be no clear trend seen with the calculated RMS velocity
data at different shear stresses (Fig. 6 A). A plot of average
RMS rolling velocity as a function of average microsphere
rolling velocity for all conditions tested shows a linear
relationship between RMS velocity and average rolling
velocity (Fig. 6 C) similar to previously described (29).
AD simulations
By matching AD simulations to the comprehensive data set
from these cell-free rolling experiments, we can estimate the
Bell model parameters, k0r and g, of the wt I-domain-ICAM-1
bond. AD accounts for the experimental settings of ﬂow
shear rate, bead size, and adhesion molecule site densities of
both ﬂow chamber and beads. The intrinsic forward reaction
rate, k0f ; and the Bell model parameters remain as tunable
inputs.
Initial simulations employed Bell model parameters for
the resting LFA-1-ICAM-1 bond measured using atomic
force microscopy, k0r ¼ 4:0 s1 and g ¼ 1.5 A˚ (36); how-
ever, simulations using these values could not approximate
the experimental data, despite manipulation of k0f : Noting
that k0r ¼ 4:0 s1 is of the same order of magnitude as
BIAcore measurements of the reverse reaction rate for wt
I-domain-ICAM-1 interactions (5.55 6 0.65 s1) (18), we
chose to hold k0r ﬁxed at this value. By allowing the reactive
compliance as well as the forward rate to vary, we found
a best ﬁt to the experimental data using k0f ¼ 0:1mm2=s;
k0r ¼ 4:0 s1; and g ¼ 0.1 A˚ (Fig. 7). These parameters are
not strictly unique; rather, they are the best global ﬁt to the
experimental data. Values of k0f between 0.2 and 0.4 mm
2/s,
with g held at 0.1 A˚, provide ﬁts of lesser quality. Values
of k0f beyond these bounds do not ﬁt the data at all. With k
0
f
held at 0.3 mm2/s, lesser quality ﬁts result from values of g
ranging between 0.15 and 0.09 A˚. Values of g beyond these
bounds do not ﬁt the data.
Consistent with experiment, simulations did not demon-
strate rolling within the experimental range of shear rates for
beads coated with 94 I-domain sites/mm2 (lowest bead site
density) over a surface with 67 ICAM-1 sites/mm2 (1.25 mg/
mL ICAM-1-coated surface)(data not shown). Simulations
of 94 sites/mm2 I-domain beads ﬂowing over surfaces of
either 122 or 210 sites/mm2 ICAM-1 (Fig. 7, A and B) dem-
onstrated transient bead-surface interaction at 220 s1 shear
rate unlike experimental data (Fig. 3, A and B); however, the
simulated bead rolling velocity was so high that correspond-
ing experimental measurements would not have observed
this behavior as rolling (data not shown).
Also in line with experimental measurements, the exami-
nation of instantaneous velocity of simulated beads shows
that pause time decreases with increasing wall shear stress. A
cell is considered to be paused when its velocity is ,1% of
the hydrodynamic velocity. Fig. 8 shows instantaneous roll-
ing velocity traces of simulated microspheres rolling on 122
sites/mm2 ICAM-1 surfaces as a function of shear rate and
I-domain microsphere site density. Similar to experimental
data shown in Fig. 5, A and B, the frequency of microsphere
pauses decreases to zero as the shear rate increases from
70 s1 (Fig. 8 A) to 180 s1 (Fig. 8 B) for particles with 252
sites/mm2 I-domain interacting with surfaces coated with
2.5 mg/ml. Also, average time paused by simulated micro-
spheres increases with increase in I-domain and ICAM-1 site
FIGURE 4 Contour plots showing the effect of (A) I-domain site density
(at 1.25 mg/mL ICAM-1 coating) and (B) ICAM-1 substrate coating
concentration (at 824 sites/mm2 of I-domain) on microsphere rolling velocity
sensitivity to wall shear stress in ﬂow chamber. (Legend) Average
microsphere rolling velocity range.
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densities on microspheres and substrate surfaces (data not
shown), respectively. As an example, at 70 s1 shear rate and
122 sites/mm2 ICAM-1 site density, an increase in I-domain
site density from 94 to 252 sites/mm2 increases the per-
centage of time paused from 75% to 83%. Holding I-domain
site density constant at 252 sites/mm2, an increase in ICAM-1
site density from 122 to 210 further increases pause time to
95% (data not shown).
DISCUSSION
LFA-1 is the major adhesive molecule expressed on
leukocytes involved in the ﬁrm adhesion of these cells to
inﬂamed endothelium in vivo. This b2-integrin binds to
ICAMs on endothelial cells, after a switch to an active
conformation mediated by signals from within transiently
adhered cells. Recent work has focused on understanding the
basis of LFA-1 afﬁnity regulation and its effect on leukocyte
adhesion. Particularly, researchers have focused on the
I-domain of LFA-1 as the major domain involved in LFA-1
ligand binding, and these efforts have led to solving the
crystal structure of LFA-1 I-domain (17,41). Molecular
biology allows for the possibility of isolated expression of
these molecules on cell surface to study their biophysical
contribution(s) to leukocyte adhesion in inﬂammation. To
this end, Springer and co-workers recently showed that the
wt I-domain of LFA-1 and one locked in an open, high
afﬁnity conformation can, respectively, support rolling and
ﬁrm adhesion of cells on ICAM-1 substrates in shear ﬂow
when expressed in aLb2 heterodimers or as isolated domains
on cell surfaces (10). However, this work and others (19) did
not fully explore the ability of these molecules, particularly
the wt I-domain, to mediate the capture of cells from free
stream similar to selectin-mediated capture and rolling on
leukocytes both in vitro and in vivo. Furthermore, to our
knowledge, no work exists exploring the dynamics of rolling
mediated by wt I-domain.
In this work, we present results from cell-free adhesion
assays done to explore the potential ability of wt I-domain in
mediating the capture and rolling of particles in ﬂow at
a range of shear stresses. This type of cell-free adhesion
assay can allow for elucidating biophysical characteristics of
I-domain-ICAM-1 interactions that are important in leuko-
cyte adhesion, particularly through the control of I-domain
FIGURE 5 Comparison of instantaneous ve-
locity traces of I-domain-coated SuperAvidin
microspheres. Top panel compares traces for
microspheres coated with 100% I-domain
interacting with ICAM-1 surfaces (2.5 mg/mL
coating) at shear rates of (A) 70 s1 and (B)
210 s1. Middle panel compares traces of
microspheres coated with (C) 100% and (D)
70% I-domain interacting with ICAM-1 sur-
faces (2.5 mg/mL coating) at a shear rate of
180 s1. Bottom panel compares traces of mi-
crospheres coated with 100% I-domain inter-
acting on surfaces coated with (E) 5 mg/ml and
(F) 1.25 mg/ml ICAM-1 at 130 s1.
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surface density on the microspheres. Speciﬁcally, ;10 mm-
sized polystyrene particles whose surfaces have been
modiﬁed with wt I-domain were perfused over ICAM-1-
coated surfaces in a parallel plate ﬂow chamber. We show
that, at all shear rates studied, wt I-domain can independently
mediate the capture of polystyrene particles from ﬂow when
interacting with ICAM-1 surfaces, similar to selectin-ligand
interaction and support-sustained rolling of microspheres
on ICAM-1 surfaces. Contrary to previous work with wt
I-domain expressed on cells by Springer and co-workers
(10), I-domain microspheres did not ﬁrmly adhere to ICAM-1
substrate in all conditions tested. This could be due to
differences in microspheres and cells’ surface morphology
and is not likely due to the differences in I-domain and
LFA-1 since Salas et al. showed higher levels of ﬁrm
adhesion for I-domain-expressing cells over those express-
ing an aLb2 heterodimer in the presences of Ca
21 and Mg21
(Fig. 3 in Salas et al. (10)). Furthermore, the presence of
EDTA, a divalent ion chelator, in the perfusion buffer
completely eliminated tethering and rolling of I-domain
microspheres on ICAM-1 (Fig. 2), suggesting the presence
FIGURE 6 Average RMS velocities of microspheres (n ¼ 3) (A) as
a function of shear rate for particles with different I-domain site density
interacting with surfaces coated with 2.5 mg/mL ICAM-1, (B) as a function
of ICAM-1 substrate coating concentration for 100% I-domain particles
(;1730 sites/mm) at 130 s1, and (C) as a function of average particle
rolling velocity for all sites of I-domain and ICAM-1 densities tested at
different wall shear stress. Error bar represents standard error calculations.
FIGURE 7 Simulated and experimental rolling velocity data for I-domain
microspheres on (A) 210, (B) 122, and (C) 67 sites/mm2 ICAM-1 surfaces.
g ¼ 0.1 A˚; k0r ¼ 4 s1; and k0f ¼ 0:3mm2=s: Error ¼ standard deviation
(n $ 7).
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of divalent cations is necessary for I-domain-microsphere
interactions, in agreement with previous publications
(18,42). Experiments conducted with microspheres pre-
incubated with the function-blocking antibody, TS2/6, at
;20 mg/mL show ;60% reduction in ﬂux of rolling for
microspheres coated with 1730 sites/mm2 of I-domain (Fig.
2), and the particles that were rolling, in this case, did so with
an average velocity that was 20 times faster (from 2.4 to
48 mm/s) than particles rolling in the absences of TS2/6.
The lack of complete (100% reduction in ﬂux) blocking
of tethering by TS2/6 at ;20 mg/mL for beads with 1730
sites/mm2 I-domain as reported in previous publications
(10) suggests the use of a nonsaturating concentration of
antibody. Limited supply of antibody prevented the use of
higher concentrations for blocking experiments. However,
we were able to show complete blocking of rolling inter-
action (;98% reduction in ﬂux from a baseline of 264 bead/
mm23min) with the same concentration of TS2/6 when the
amount of I-domain on microspheres was reduced by ;½
(824 sites/mm2) (Fig. 2). Overall, the magnitude of rolling
velocities obtained with I-domain microspheres in this work
were in the range (0–60mm/s), similar to previously obtained
for wt I-domain expressed on K562 cells (10).
Previous work with cell-expressed wt I-domain interacting
with ICAM-1 substrate from ﬂow show that rolling velocity
of these cell increases with increasing wall shear stress;
however, these authors did not explore the effect of I-domain
density (or ICAM-1 density) on rolling (10,19). As pre-
viously shown with selectin-mediated rolling, I-domain mi-
crospheres’ rolling interactions depend on wall shear stress
within the ﬂow chamber, as well as receptor (I-domain) and
ligand (ICAM-1) density on microsphere and substrate sur-
faces, respectively (21,29). The effect of wall shear on rolling
velocity appears to be coupled to the molecule site density.
In Fig. 4, we show that at the highest density of I-domain
(;1700 sites/mm2) on microsphere surfaces and ICAM-1
density on substrate surfaces (;210 sites/mm2), microsphere
rolling velocity appears to be insensitive to wall shear stress
(Fig. 4 A). However, at low I-domain or ICAM-1 densities or
a combination of both (Fig. 4 C), microsphere rolling veloc-
ities show more sensitivity to shear stress, where velocity
increased linearly with an increase in wall shear stress over
the range of shear stresses studied. At intermediate level of
I-domain and ICAM-1 densities, there exist two regimes
where the sensitivity of rolling velocity to wall shear stress is
different—one of low sensitivity to an increase in shear stress
occurring at low wall shear stress and the other of high sen-
sitivity to increase in shear stress occurring at higher wall
shear stresses within the ﬂow chamber (see squares in Fig.
4). This observation is also consistent with the rolling in-
teraction seen with cell-expressed I-domain or aLb2, where
multiple slopes exist in the plot of rolling velocities as a
function of shear stress (10). Overall, the data present in Fig.
4 suggest that at the highest I-domain and ICAM-1 densities,
there exists an excess of I-domain-ICAM-1 bonds in the
contact region to withstand the counteracting force from ﬂow
over the range of shear stresses studied.
Instantaneous rolling provides another way of character-
izing the rolling dynamics of wt I-domain-coated micro-
spheres on ICAM-1 substrates. Results presented in Fig. 6
show that microspheres displayed pause interactions when
interacting with ICAM-1 substrates in ﬂow, similar to what
has been previously described for selectin-mediated rolling
of neutrophils in ﬂow (21). We also show that the potential
for pause interaction seen with I-domain microspheres is a
function of molecular density and wall shear stress, suggest-
ing that these pauses are due to receptor-ligand interaction,
rather than nonspeciﬁc interaction between polystyrene
FIGURE 8 Effect of I-domain site density and shear stress on simulated
bead instantaneous velocity distribution. Instantaneous velocity traces of
simulated microspheres rolling on 122 sites/mm2 ICAM-1 surfaces.
Simulated microspheres with 252 sites/mm2 I-domain interacting ICAM-1
at a shear rate of (A) 70 s1 and (B) 180 s1. Panel C depicts a simulated
trace for microspheres with 94 sites/mm2 I-domain at 180 s1 shear rate. g ¼
0.1 A˚; k0r ¼ 4 s1; k0f ¼ 0:3mm2=s:
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microspheres and substrate surfaces. Similarly, analysis of
the RMS rolling velocity data, as described in a previous
publication (29), shows I-domain microspheres rolling with
varying velocity on ICAM-1-coated surfaces. Furthermore,
ﬂuctuation in rolling velocity with time increases with a
decrease in microsphere and substrate I-domain and ICAM-1
density, respectively (Fig. 7), similar to ﬂuctuations seen in
selectin-mediated rolling of particles in ﬂow (21,29). Once
again, this observation suggests that ﬂuctuation in rolling
velocity with time is a result of ﬂuctuation in I-domain-
ICAM-1 binding, in agreement with previous predictions by
Hammer and Apte using dynamics simulation (30). A plot
of RMS rolling velocities as a function of average particle
rolling velocity for all conditions tested shows a linear re-
lationship between these two parameters, suggesting that
rolling velocity sets ﬂuctuations in rolling, i.e., measurement
of the rolling velocity of a particle can predict the magnitude
of ﬂuctuation in rolling velocity for that particle (Fig. 6 C).
Results from AD simulation of I-domain-ICAM-1 rolling
interactions show a good correlation with experimental data
and suggest an off rate and reactive compliance for I-domain-
ICAM-1 interactions of 4 s1 and 0.1 A˚, respectively. These
values are within the same magnitude of values determined
for selectin-carbohydrate interaction, suggesting a rolling
behavior of I-domain particles on ICAM-1 substrates as seen
with experiments (22). As with experiments, AD shows ﬂuc-
tuation in rolling velocity and the amount of time paused that
increases with wall shear stress and I-domain and ICAM-1
microspheres and substrate density, respectively (Fig. 8).
The important role of molecular densities in prescribing
rolling dynamics of I-domain-coated microspheres further
highlights the importance of I-domain (LFA-1) expression
level in the ability of this molecule to support rolling adhe-
sion in vivo. Work by Alon and co-workers shows that
LFA-1-mediated rolling is independent of ligand afﬁnity to
LFA-1 but rather dependent on an afﬁnity-independent
mechanism of integrin clustering (20). In this work, we show
an absence of tethering or rolling of microspheres at a com-
bination of very low I-domain (94 sites/mm2) and ICAM-1
(;67 sites/mm2) densities, supporting the idea that low
avidity of LFA-1 rather than afﬁnity to ICAM-1 might
prevent the ability of this integrin to mediate in vivo tethering
of leukocytes in the absence of selectin-carbohydrate in-
teraction.
Finally, work exists in the literature that suggests the con-
tribution of b2-integrin to selectin-mediated rolling—where
leukocytes are observed to display faster rolling in the
absence of b2-integrin interactions (13,19). The observed
similarity in the dynamics of cell-free I-domain rolling
adhesion on ICAM-1 described here to that of previously
published selectin-mediated rolling further highlight the
possibility that the I-domain of LFA-1 in its inactive state
contributes to the capture and rolling of neutrophils in vivo.
Furthermore, evidence in the literature suggests that LFA-1
is the important b2-integrin involved in the in vivo transition
of leukocytes from rolling to ﬁrm adhesion (14,43). Also,
previous work in our laboratory showed that the transition
from selectin-mediated rolling to b2-integrin-mediated ﬁrm
binding occurs in a gradual process when particles co-
functionalized with the rolling ligand, sLeX, and an antibody
to ICAM-1 with similar binding kinetics to active LFA-1
were allowed to interact with surfaces coated with both
selectin and ICAM-1 in ﬂow (27). In this previously
described cell-free work, we showed that ICAM-1-antibody
interactions also slow rolling similar to ICAM-1-b2-integrin
interaction in vivo and that selectin-carbohydrate interaction
was necessary for optimum ﬁrm binding mediated by the
antibody-ICAM-1 interactions. It is possible that this type of
interplay between leukocyte rolling and ﬁrm adhesion in
itself could serve as a dynamic regulation for the system of
adhesion seen with leukocytes, and work by Simon and co-
workers, where rolling neutrophils on E-selectin transition to
ﬁrmly adherent cells in the absence of chemotactic stimu-
lation, allude to this fact (44). Moreover, Springer and co-
workers (22) previously suggested that force (from tethering)
alone is sufﬁcient to shift the conformation of wt I-domain
toward the open, high afﬁnity conformation, thereby in-
creasing its afﬁnity to ICAM-1 (10). Furthermore, they re-
cently showed that the extension of aLb2 is critical for the
rolling and ﬁrm binding supported by this molecule (45). All
together, this suggests that selectin-mediated rolling sup-
ported by LFA-1 (b2-integin) transient interactions can allow
for enough force from ﬂow that results in the transition of
LFA-1 to its active state to support the ﬁrm arrest of these
cells to the endothelium. Work is underway to characterize
the adhesion of particles functionalized with the I-domain of
LFA-1 locked in the open position that mimics the active
state of the molecule in vivo and to understand how selectins
and I-domain might act in synergy to support rolling and ﬁrm
adhesion. Overall, we believe the cell-free adhesion system
presented in this work can be adapted to ﬁt cell systems to
further elucidate the role of LFA-1 and its adhesion domains
in leukocyte interaction with endothelial cells during in-
ﬂammation response.
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